ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOS BioPlus Acquisition Corporation

10.795
0.00 (0.00%)
18 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
BioPlus Acquisition Corporation NASDAQ:BIOS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.795 10.79 11.28 0 01:00:00

Stull, Stull & Brody is Investigating Claims on Behalf of BioScrip, Inc. Shareholders

22/09/2015 1:46am

GlobeNewswire Inc.


BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart


From Oct 2019 to Oct 2024

Click Here for more BioPlus Acquisition Charts.

Stull, Stull & Brody today announced that a complaint has been filed and that it has commenced an investigation relating to BioScrip, Inc.'s ("BioScrip" or the "Company") (NASDAQ:BIOS) Dead Hand Proxy Put in the Company's August 6, 2015, fourth amendment of a credit agreement dated July 31, 2013, for which SunTrust is the administrative agent (the "Credit Agreement").

The Credit Agreement contains a Dead Hand Proxy Put which permits SunTrust to accelerate payment for all outstanding debt and unpaid interest if a majority of the Board is replaced as the result of a proxy contest initiated not on or on behalf of the Board.  The purpose and effect of the Dead Hand Proxy Put is to deter proxy contests and entrench the incumbent Board. Stull, Stull & Brody is investigating whether the Dead Hand Proxy Put is a violation of fiduciary duties owed to BioScrip's shareholders by its Board of Directors, and whether the Dead Hand Proxy Put should be enjoined.

If you hold BioScrip stock and have questions about your legal rights or interests with respect to these matters, please contact Michael Klein, Esq. at Stull, Stull & Brody by e-mail at BIOS@ssbny.com, by calling toll-free 1-800-337-4983 x147, by fax to 1-212-490-2022, or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017. You can also visit our website at www.ssbny.com.

You may retain Stull, Stull & Brody, or other counsel of your choice, to represent you. Stull, Stull & Brody has litigated many class actions for violations of securities laws in federal courts over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in New York and Beverly Hills.

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.

1 Year BioPlus Acquisition Chart

1 Year BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart

1 Month BioPlus Acquisition Chart